Application Sponsors
ANDA 079158 | LANNETT CO INC | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | 1MG/ML | 0 | RISPERIDONE | RISPERIDONE |
FDA Submissions
| ORIG | 1 | AP | 2010-12-03 | |
LABELING; Labeling | SUPPL | 2 | AP | 2011-10-26 | |
LABELING; Labeling | SUPPL | 3 | AP | 2011-11-04 | |
LABELING; Labeling | SUPPL | 5 | AP | 2012-01-30 | |
LABELING; Labeling | SUPPL | 9 | AP | 2012-10-22 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2015-11-12 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 3 | Null | 15 |
SUPPL | 5 | Null | 15 |
SUPPL | 9 | Null | 15 |
SUPPL | 10 | Null | 15 |
TE Codes
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 79158
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"1MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"1MG\/ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)